Cancer cells often upregulate anti-apoptotic BCL-2 proteins, thus tilting the ratio of anti- versus pro-apoptotic members to fall in favor of apoptosis evasion, even in the presence of stimuli from chemotherapeutic agents [6]. This evidence concerns the gene BCL2 and cancer.